WASHINGTON, DC – The Bipartisan Heroin Task Force, led by Representatives Donald Norcross (D-NJ), Tom MacArthur (R-NJ), Annie Kuster (D-NH) and Brian Fitzpatrick (R-PA), is urging Congress to provide expanded funding for the Comprehensive Addiction and Recovery Act (CARA). Currently, both the House and Senate FY 2018 appropriations bills provide funding for CARA, but there are differences in the funding levels. 

The Bipartisan Task Force is asking Congress to reconcile the differences of these bills by adopting the highest level of funding. Additionally, Congress should also consider devoting a substantial portion of the opioid funds promised by the Balanced Budget Agreement, which the Task Force fought for, as supplemental funding for all the grant programs authorized by CARA. Last year, the Task Force successfully fought to fully fund CARA.  54 additional members joined the co-chairs and vice-chairs in this request.

“Designed to respond to both today’s crisis and tomorrow’s threats, CARA represents a comprehensive response to substance use disorders that includes preventive measures, support for law enforcement strategies, resources to address overdoses, expansion of evidence-based treatment and support for those in or seeking recovery,” wrote the Bipartisan Task Force. “We strongly urge you to fully fund CARA at its authorized levels and consider devoting a substantial portion of the funds promised by the Balanced Budget Agreement as supplemental funding for all the grant programs authorized by CARA.”

Full Letter Text:

Dear Chairman Frelinghuysen and Ranking Member Lowey:

As Members of Congress focused on a comprehensive response to our nation’s opioid crisis, we write to urge you to provide expanded funding in the final Fiscal Year 2018 omnibus appropriations act and in the Fiscal Year 2019 Labor- Health and Human Services appropriations act to the Comprehensive Addiction and Recovery Act (CARA). While both the House and Senate FY 2018 appropriations bills provide funding for CARA programs, there are some differences in these funding levels. Also, additional funding to combat the opioid epidemic was agreed to by both chambers of Congress under the February 7th Balanced Budget Agreement. As such, we urge you to reconcile these differences by adopting the highest funding level in each of these CARA accounts for both Fiscal Year 2018 and Fiscal Year 2019.

As you know, the opioid epidemic is having a devastating impact on public health and safety across the United States. According to the Centers for Disease Control’s most recent statistics, drug overdoses now surpass automobile accidents as the leading cause of injury-related death for Americans aged 25 to 64. More than 174 Americans die as a result of overdose every day. While addiction is a treatable disease, only about ten percent of those who need treatment receive it, and we are witnessing the devastating impact of this situation in communities across our nation.

We know from researchers, the law enforcement community, and treatment providers that the most effective way to address the challenges posed by addiction is to initiate a comprehensive response to the twin epidemics of opioid and heroin addiction. Designed to respond to both today’s crisis and tomorrow’s threats, CARA represents a comprehensive response to substance use disorders that includes preventive measures, support for law enforcement strategies, resources to address overdoses, expansion of evidence-based treatment and support for those in or seeking recovery.

Among other provisions, CARA expands:

• Prevention and educational efforts – particularly aimed at teens, parents and other caretakers, and ageing populations – to prevent the abuse of opioids and heroin.
• The availability of naloxone to law enforcement agencies and other first responders.
• Treatment resources to promptly identify and treat individuals suffering from addiction disorders in the criminal justice system.
• Disposal sites for unwanted prescription medications to keep them out of the hands of our children and adolescents.
• Evidence-based addiction treatment and intervention programs to expand best practices throughout the country.
• Medication assisted treatment demonstrations across the country.
• Veterans Treatment Courts to expand evidence-based treatment and peer-to-peer services.

As you finalize your work on the rest of the Fiscal Year 2018 omnibus appropriations and the Fiscal Year 2019 appropriations act, we note the additional $6 billion in Fiscal Years 2018 & 2019 funding promised to combat the opioid epidemic as part Balanced Budget Agreement. We strongly urge you to  fully fund CARA at its authorized levels and consider devoting a substantial portion of the funds promised by the Balanced Budget Agreement as supplemental funding for all the grant programs authorized by CARA.

While CARA represents an important step toward a comprehensive framework to help individuals with substance use disorder, the perilous costs to our communities and economies demands greater action. In 2016, over 63,000 people died to drug overdose. The White House Council of Economic Advisers reported that the nation suffered an estimated $504 billion economic cost due to the opioid and heroin epidemic. It is clear more must be done. We are appreciative that House Appropriators have acknowledged this need with the Budget Agreement.

We know you will continue to take action against this epidemic in our midst and provide the funding necessary to support the comprehensive response framework provided in CARA. Doing so would provide the resources and incentives necessary for states and local governments to expand treatment, prevention and recovery efforts for the millions of Americans who are affected by this deadly disease.

We appreciate your leadership and continued support in helping us address the opioid crisis through CARA funding in the Fiscal Years 2018 & 2019 appropriations acts. Only through a comprehensive approach that leverages evidence-based law enforcement and health care services can we stop and reverse the current trend.  Thank you for your consideration of our important funding request.

Representatives Mark DeSaulnier (D-CA), Debbie Dingell (D-MI), Glenn Thompson (R-PA), Tom O'Halleran (D-AZ), John Yarmuth (D-KY), Elizabeth Esty (D-CT), Barbara Comstock (R-VA), Elise Stefanik (R-NY), Ryan Costello (R-PA), Jack Bergman (R-MI), Jackie Walorski (R-IN), Jamie Raskin (D-MD), James McGovern (D-MA), Tom Claudia Tenney (R-NY), Brian Fitzpatrick (R-PA), Cheri Bustos (D-IL), Steve Knight (R-CA), Sean Patrick Maloney (D-NY), Lois Frankel (D-FL), Scott Peters (D-CA), Lisa Blunt Rochester (D-DE), Keith Rothfus (R-PA), Bruce Poliquin (R-ME), Bill Foster (D-IL), Luke Messer (R-IN),  Seth Moulton (D-MA), Andy Barr (R-KY), Bradley Schneider (D-IL), John Larson (D-CT), Mark Takano (D-CA), Kathleen Rice (D-NY), Carol Shea-Porter (D-NH), Donald Norcorss (D-NJ), Hakeem Jeffries (D-NY), John Katko (R-NY), John Delaney (D-MD), Niki Tsongas (D-MA), Kyrsten Sinema (D-AZ), Rodney Davis (R-IL), Diana DeGette (D-CO), Chellie Pingree (D-ME), David Cicilline (D-RI), Stephen Lynch (D-MA), Peter Welch (D-VT), Patrick Meehan (R-PA), Sean Duffy (R-WI), Joe Courtney (D-CT), William Keating (D-MA), Michael Turner (R-OH), Bill Pascrell (D-NJ), Frank LoBiondo (R-NJ), Bob Gibbs (R-OH), Ted Deutch (D-FL), Brian Higgins (D-NY), Suzan DelBene (D-WA) joined the Bipartisan Heroin Task Force co-chairs on this letter.

###

Contact: Ally Kehoe, Communications Director
ally.kehoe@mail.house.gov